Hardman Johnston Global Advisors’s Merck MRK Stock Holding History

Hardman Johnston Global Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.35M	Sell	11,210 -1,540	-12%	-$178K	0.06%	58
2025 Q4	$1.34M	Hold	12,750	–	–	0.06%	57
2025 Q3	$1.07M	Hold	12,750	–	–	0.05%	56
2025 Q2	$1.01M	Hold	12,750	–	–	0.04%	57
2025 Q1	$1.14M	Hold	12,750	–	–	0.05%	58
2024 Q4	$1.27M	Hold	12,750	–	–	0.05%	63
2024 Q3	$1.45M	Hold	12,750	–	–	0.06%	60
2024 Q2	$1.58M	Hold	12,750	–	–	0.06%	58
2024 Q1	$1.68M	Hold	12,750	–	–	0.06%	59
2023 Q4	$1.39M	Hold	12,750	–	–	0.04%	61
2023 Q3	$1.31M	Hold	12,750	–	–	0.04%	63
2023 Q2	$1.47M	Hold	12,750	–	–	0.05%	62
2023 Q1	$1.36M	Hold	12,750	–	–	0.04%	60
2022 Q4	$1.41M	Hold	12,750	–	–	0.06%	62
2022 Q3	$1.1M	Hold	12,750	–	–	0.05%	59
2022 Q2	$1.16M	Hold	12,750	–	–	0.05%	59
2022 Q1	$1.05M	Hold	12,750	–	–	0.03%	60
2021 Q4	$977K	Hold	12,750	–	–	0.03%	58
2021 Q3	$958K	Hold	12,750	–	–	0.03%	58
2021 Q2	$992K	Sell	12,750 -612	-5%	-$45.5K	0.02%	59
2021 Q1	$983K	Hold	13,362	–	–	0.03%	58
2020 Q4	$1.04M	Hold	13,362	–	–	0.03%	60
2020 Q3	$1.06M	Hold	13,362	–	–	0.04%	59
2020 Q2	$986K	Hold	13,362	–	–	0.04%	58
2020 Q1	$981K	Hold	13,362	–	–	0.06%	58
2019 Q4	$1.16M	Hold	13,362	–	–	0.05%	59
2019 Q3	$1.07M	Hold	13,362	–	–	0.05%	55
2019 Q2	$1.07M	Sell	13,362 -314	-2%	-$24K	0.05%	57
2019 Q1	$1.08M	Hold	13,676	–	–	0.05%	57
2018 Q4	$997K	Sell	13,676 -105	-0.8%	-$7.41K	0.05%	56
2018 Q3	$933K	Hold	13,781	–	–	0.04%	58
2018 Q2	$798K	Hold	13,781	–	–	0.03%	59
2018 Q1	$716K	Hold	13,781	–	–	0.03%	59
2017 Q4	$740K	Hold	13,781	–	–	0.03%	61
2017 Q3	$842K	Hold	13,781	–	–	0.04%	61
2017 Q2	$843K	Hold	13,781	–	–	0.04%	66
2017 Q1	$836K	Sell	13,781 -105	-0.8%	-$6.37K	0.04%	65
2016 Q4	$780K	Buy	13,886 +105	+0.8%	+$6.14K	0.04%	65
2016 Q3	$821K	Hold	13,781	–	–	0.04%	64
2016 Q2	$758K	Hold	13,781	–	–	0.04%	65
2016 Q1	$696K	Buy	13,781 +1,614	+13%	+$79K	0.04%	64
2015 Q4	$613K	Hold	12,167	–	–	0.04%	63
2015 Q3	$573K	Hold	12,167	–	–	0.04%	60
2015 Q2	$661K	Hold	12,167	–	–	0.04%	61
2015 Q1	$667K	Sell	12,167 -839	-6%	-$47.5K	0.04%	64
2014 Q4	$705K	Hold	13,006	–	–	0.04%	66
2014 Q3	$736K	Hold	13,006	–	–	0.04%	65
2014 Q2	$718K	Hold	13,006	–	–	0.04%	67
2014 Q1	$705K	Hold	13,006	–	–	0.04%	68
2013 Q4	$621K	Hold	13,006	–	–	0.04%	67
2013 Q3	$591K	Hold	13,006	–	–	0.04%	66
2013 Q2	$576K	Buy	+13,006	New	+$581K	0.04%	67

Other funds holding MRK

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Hardman Johnston Global Advisors's MRK Position: Q1 2026 in Review

Hardman Johnston Global Advisors reduced its Merck (MRK) stake by 12% in Q1 2026, selling an estimated $178K and leaving 11,210 shares worth $1.35M. The position accounts for 0.06% of the portfolio, ranked #58.

Hardman Johnston Global Advisors first reported a position in MRK in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.68M in Q1 2024. 3,780 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

Hardman Johnston Global Advisors held 11,210 shares of Merck worth $1.35M as of Q1 2026.
Hardman Johnston Global Advisors sold 1,540 Merck shares in Q1 2026, an estimated $178K.
Merck made up 0.06% of Hardman Johnston Global Advisors's portfolio in Q1 2026, its #58 holding.
Hardman Johnston Global Advisors first reported a position in Merck in Q2 2013 and has held it in 52 quarters since.
Hardman Johnston Global Advisors's Merck position peaked at $1.68M in Q1 2024.
3,780 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Hardman Johnston Global Advisors's 13F filing for Q1 2026, filed 13 May 2026.